How FDA Decisions Impact Your Pending Drug Approvals
Phase3.bio places the FDA review team’s deliberative process for drug evaluation into perspective so directors of research at drug development companies better understand the implications for their pending drug approvals.
The site features expert biostatistical analysis from highly skilled PhDs, scrutiny of meeting minutes, insight on voting patterns, exploration of FDA rebuttals, in-depth study analysis, and details on discussions and meeting minutes.
Phase3.bio synthesizes analysis into a case report that includes a video presentation that summarizes the documentation, all narrated by a drug development expert, along with downloadable PDF and web versions that include detailed links and citations. All the resources on the site are free after a quick registration.
Welcome to our site. Please take a look around and give us your feedback.